CA2118489A1 - 5-O-Desosaminylerythronolide a Derivatives - Google Patents

5-O-Desosaminylerythronolide a Derivatives

Info

Publication number
CA2118489A1
CA2118489A1 CA 2118489 CA2118489A CA2118489A1 CA 2118489 A1 CA2118489 A1 CA 2118489A1 CA 2118489 CA2118489 CA 2118489 CA 2118489 A CA2118489 A CA 2118489A CA 2118489 A1 CA2118489 A1 CA 2118489A1
Authority
CA
Canada
Prior art keywords
group
desosaminylerythronolide
derivatives
represented
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2118489
Other languages
French (fr)
Other versions
CA2118489C (en
Inventor
Toshifumi Asaka
Masato Kashimura
Yoko Misawa
Shigeo Morimoto
Katsuo Hatayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2118489A1 publication Critical patent/CA2118489A1/en
Application granted granted Critical
Publication of CA2118489C publication Critical patent/CA2118489C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Abstract

Object: To provide novel macrolide antibiotics having a strong antibacterial activity.
Constitution: 5-O-desosaminylerythronolide A
derivatives represented by the formula:
(see fig. I) [wherein -A~ is a group of -N(R3)- (wherein R3 is a hydrogen atom or an alkyl group having 1 - 3 carbon atoms) or a group represented by -N=, and R1 and R2 are each a hydrogen atom or an alkyl group having 1 - 3 carbon atoms] which is a tricyclic carbamate of 5-O-desosaminylerythronolide A derivative having a ketone at the 3-position, being substituted by a methoxy group at the 6-position, and a pharmaceutically acceptable acid addition salt thereof; and a compound represented by the formula:

(see fig. II) (wherein R4 is an acetyl group or a propionyl group) which is an intermediate useful for the preparation of the 3-ketone forms of 5-O-desosaminylerythronolide A
derivatives.
CA002118489A 1992-04-22 1993-04-21 5-o-desosaminylerythronolide a derivatives Expired - Fee Related CA2118489C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10149292 1992-04-22
JP04-101492 1992-04-22
PCT/JP1993/000517 WO1993021200A1 (en) 1992-04-22 1993-04-21 5-o-desosaminylerythronolide a derivative

Publications (2)

Publication Number Publication Date
CA2118489A1 true CA2118489A1 (en) 1993-10-23
CA2118489C CA2118489C (en) 1999-07-13

Family

ID=14302174

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002118489A Expired - Fee Related CA2118489C (en) 1992-04-22 1993-04-21 5-o-desosaminylerythronolide a derivatives
CA002118488A Expired - Fee Related CA2118488C (en) 1992-04-22 1993-04-21 5-o-desosaminylerythronolide a derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002118488A Expired - Fee Related CA2118488C (en) 1992-04-22 1993-04-21 5-o-desosaminylerythronolide a derivative

Country Status (12)

Country Link
US (2) US5591837A (en)
EP (2) EP0638585B1 (en)
KR (2) KR0166996B1 (en)
AT (2) ATE135707T1 (en)
AU (2) AU662420B2 (en)
BR (1) BR1100235A (en)
CA (2) CA2118489C (en)
DE (2) DE69301916T2 (en)
DK (2) DK0638585T3 (en)
ES (2) ES2096915T3 (en)
GR (2) GR3019787T3 (en)
WO (2) WO1993021200A1 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38426E1 (en) 1995-10-09 2004-02-10 Aventis Pharma S.A. 5-O-deosaminyl 6-O-methyl erythronolide A derivatives, preparation method therefor and use thereof for preparing biologically active materials
FR2739620B1 (en) * 1995-10-09 1997-12-19 Roussel Uclaf NOVEL DERIVATIVES OF 5-0-DESOSAMINYL 6-O-METHYL ERYTHRONOLIDE A, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO THE PREPARATION OF BIOLOGICALLY ACTIVE PRODUCTS
US5747466A (en) * 1995-11-08 1998-05-05 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
ATE259823T1 (en) * 1995-11-08 2004-03-15 Abbott Lab TRICYCLIC ERYTHROMYCIN DERIVATIVES
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
UA51730C2 (en) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-0-substituted ketolides having antibacterial activity
KR100576988B1 (en) * 1996-09-04 2006-05-10 아보트 러보러터리즈 6-0-substituted ketolides having antibacterial activity
IL129946A0 (en) 1996-11-27 2000-02-29 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
FR2757168B1 (en) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
WO1998040392A1 (en) * 1997-03-10 1998-09-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6140479A (en) * 1997-03-24 2000-10-31 Taisho Pharmaceuticals Co., Ltd. Erythromycin a derivatives
US6162794A (en) * 1997-05-09 2000-12-19 Pfizer Inc. Erythromycin derivatives
PL337066A1 (en) * 1997-05-29 2000-07-31 Abbott Lab Polycyclic derivatives of erythromycin
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
US5780604A (en) * 1997-09-26 1998-07-14 Abbott Laboratories 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
US6124269A (en) * 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
CO4990960A1 (en) * 1997-10-29 2000-12-26 Abbott Lab 2-HALO-6-O SUBSTITUTED CETOLIDE DERIVATIVES
PA8461401A1 (en) * 1997-10-29 2000-05-24 Pfizer Prod Inc TRICYCLIC ERYTHROMYCINE DERIVATIVES
HN1998000159A (en) * 1997-10-29 1999-02-09 Monsanto Co DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
FR2777282B1 (en) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc NEW DERIVATIVES OF 2-FLUORO 3-DE ((2,6-DIDEOXY 3-C-METHYL 3-0-METHYL-ALPHA-L-RIBOHEXOPYRANOSYL) OXYL) 6-O-METHYL 3-OXO ERYTHROMYCIN, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO THE SYNTHESIS OF ACTIVE INGREDIENTS OF MEDICINES
PT952157E (en) * 1998-04-24 2003-11-28 Pfizer Prod Inc DERIVATIVES 9A, 11B-9-OXIMA-3-CETO-6-O-METHYLERITROMYCIN DERIVATIVES
WO1999062920A1 (en) * 1998-06-03 1999-12-09 Pfizer Products Inc. Tricyclic 3-keto derivatives of 6-o-methylerythromycin
FR2784682B1 (en) 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc NOVEL 2-HALOGEN DERIVATIVES OF 5-0-DESOSAMINYLERYTHRONOLIDE A, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6355620B1 (en) 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
NZ536402A (en) * 2002-05-13 2006-08-31 Enanta Pharm Inc 6,11 bicyclic erythromycin derivatives
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
WO2005070918A1 (en) * 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6753318B1 (en) * 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7276487B2 (en) * 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US7265094B2 (en) * 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
US7163906B2 (en) * 2004-11-04 2007-01-16 Chevron Phillips Chemical Company, Llp Organochromium/metallocene combination catalysts for producing bimodal resins
US7229972B2 (en) 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
KR100924610B1 (en) 2004-12-07 2009-11-02 이난타 파마슈티칼스, 인코포레이티드 3,6-bicyclolides
US7312201B2 (en) 2004-12-13 2007-12-25 Enanta Pharmaceuticals, Inc. Tetracyclic bicyclolides
WO2006065721A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
CN101454334B (en) 2006-05-01 2013-04-10 大正制药株式会社 Macrolide derivatives
US20070298811A1 (en) * 2006-06-21 2007-12-27 Lockheed Martin Corporation System for predicting bandwidth capacity
WO2009006403A2 (en) * 2007-06-29 2009-01-08 Georgia Tech Research Corporation Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof
US8871728B2 (en) 2007-06-29 2014-10-28 Georgia Tech Research Corporation Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
ES2691252T3 (en) * 2007-09-17 2018-11-26 Enanta Pharmaceuticals, Inc. Biaryl macrolides with bridge in 6.11
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175150A (en) * 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
CA2096969C (en) * 1990-11-28 2000-11-21 Masato Kashimura 6-0-methylerythromycin a derivatives
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives

Also Published As

Publication number Publication date
KR100244729B1 (en) 2000-02-15
BR1100235A (en) 2002-04-30
EP0638584A4 (en) 1994-12-23
CA2118488C (en) 2002-11-05
GR3021992T3 (en) 1997-03-31
KR950700921A (en) 1995-02-20
AU661585B2 (en) 1995-07-27
EP0638585B1 (en) 1996-11-13
AU4022393A (en) 1993-11-18
GR3019787T3 (en) 1996-07-31
CA2118488A1 (en) 1993-10-23
WO1993021200A1 (en) 1993-10-28
EP0638584B1 (en) 1996-03-20
DE69305987T2 (en) 1997-03-06
ATE145212T1 (en) 1996-11-15
KR0166996B1 (en) 1999-01-15
EP0638584A1 (en) 1995-02-15
CA2118489C (en) 1999-07-13
AU662420B2 (en) 1995-08-31
US5631355A (en) 1997-05-20
EP0638585A1 (en) 1995-02-15
KR950700920A (en) 1995-02-20
DK0638585T3 (en) 1996-12-02
US5591837A (en) 1997-01-07
DE69301916D1 (en) 1996-04-25
AU4022293A (en) 1993-11-18
EP0638585A4 (en) 1995-04-19
DE69305987D1 (en) 1996-12-19
DE69301916T2 (en) 1996-08-08
WO1993021199A1 (en) 1993-10-28
ATE135707T1 (en) 1996-04-15
ES2087737T3 (en) 1996-07-16
DK0638584T3 (en) 1996-04-15
ES2096915T3 (en) 1997-03-16

Similar Documents

Publication Publication Date Title
CA2118489A1 (en) 5-O-Desosaminylerythronolide a Derivatives
CA2096969A1 (en) 6-0-methylerythromycin a derivatives
IE812273L (en) Cephalosporin derivatives
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
CA2102772A1 (en) Azetidinone compound and process for preparation thereof
EP0723966A4 (en) Novel cephem derivative
DE69029781T2 (en) Anthracycline glycoside derivatives and process for their preparation
CA2111955A1 (en) Novel tetracyclic compound
CA2010982A1 (en) Osteogenesis promotion with use of vitamin d derivatives
EP0852231A3 (en) 16-Membered macrolide derivative having sustained antibacterial activity in plasma, synthesis intermediate thereof and process for producing the same
DE69409874T2 (en) 16-link macrolide derivatives and process for their preparation
CA2147264A1 (en) Vitamin d derivatives and a process for producing them
DE69620128D1 (en) Herboxidia derivatives and their preparation from a Streptomyces GEX1 culture
IE870562L (en) Penem derivatives
AU629209B2 (en) Cephalosporin compounds
AU2014188A (en) Naphthothiazepine derivatives and preparation thereof
ES8305703A1 (en) 2-Benzoylamino substituted benzylamine derivative and a process for preparation thereof.
CA2238936A1 (en) Process for the preparation of arylalkynyl-n-hydroxyurea derivatives having lipoxygenase inhibitory activity
WO1995016693A3 (en) 4'-o-sulfonyl-anthracycline derivatives
AU2208988A (en) Process for the preparation of macrolide compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20040421